Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Therapy Among Patients With Treatment-resistant Depression: a Randomised, Double-blind, Placebo-controlled Trial: Pilot Phase

NCT02401139 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT02401139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Therapy Among Patients With Treatment-resistant Depression: a Randomised, Double-blind, Placebo-controlled Trial: Pilot Phase
Lead sponsor
The University of New South Wales
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2015
Completion date
September 30, 2015
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unipolar depression